Safety in pharmacological enhancement of stroke rehabilitation

European Journal of Physical and Rehabilitation Medicine

Volumn 49, Issue 2, 2013, Pages 261-267

  Engelter, S T ^a,b  

^a Felix Platter Spital   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Neurorehabilitation; Pharmacotherapy; Recovery; Safety.; Shoke

Indexed keywords

EID: 84881461057     PISSN: 19739087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Johansson BB. Brain plasticity and stroke rehabilitation. The Willis lecture. Stroke 2000;31:223-30. (Pubitemid 30035778)
2. Duffau H. Brain plasticity: from pathophysiological mechanisms to therapeutic applications. J Clin Neurosci 2006;13:885-97. (Pubitemid 44666418)
3. Czlonkowska A, Lesniak M. Pharmacotherapy in stroke rehabilitation. Expert Opin Pharmacother 2009;10:1249-59.
4. Goldstein LB. Potential effects of common drugs on stroke recovery. Arch Neurol 1998;55:454-6. (Pubitemid 28182689)
5. Lombardi F. Pharmacological treatment of neurobehavioural sequelae of traumatic brain injury. Eur J Anaesthesiol Suppl 2008;42:131-6. (Pubitemid 351643057)
6. Bütefisch CM, Davis BC, Wise SP, Sawaki L, Kopylev L, Classen J et al. Mechanisms of use-dependent plasticity in the human motor cortex. Proc Natl Acad Sei U S A 2000;97:3661-5. (Pubitemid 30183359)
7. Lyden P, Shuaib A, Ng K, Levin K, Atkinson RP, Rajput A et al. Clomethiazole acute stroke study in ischemic stroke (CLASS-I): final results. Stroke 2002;33:122-9.
8. Kiefer F, Mann K. Encyclopedia of psychopharmacology Clomethiazol. In-. Stolerman IP, ed. Berlin, Heidelberg: Springer-Verlag; 2010. p. 56-7.
9. Manthey D, Asimiadou S, Stefovska V, Kaindl AM, Fassbender J, Ikonomidou C et al. Sulthiame but not levetiracetam exerts neurotoxic effect in the developing rat brain. Experimental Neurology 2005;193:497-503. (Pubitemid 40616197)
10. Leng Y, Fessier EB, Chuang DM. Neuroprotective effects of the mood stabilizer lamotrigine against glutamate excitotoxicity: roles of chromatin remodelling and Bcl-2 induction. Int J Neuropsychopharmacol 2012;FirstView:1-14.
11. Wang Zf, Fessier EB, Chuang DM. Beneficial effects of mood stabilizers lithium, valproate and lamotrigine in experimental stroke models. Acta Pharmacol Sin 2011;32:1433-45.
12. Hosp JA, Pekanovic A, Rioult-Pedotti MS, Luft AR. Dopaminergic projections from midbrain to primary motor cortex mediate motor skill learning. J Neurosci 2011;31:2481-7.
13. Reinholz J, Skopp O, Breitenstein C, Winterhoff H, Knecht S. Better than normal: Improved formation of long-term spatial memory in healthy rats treated with levodopa. Exp Brain Res 2009;192:745-9.
14. Knecht S, Breitenstein C, Bushuven S, Wailke S, Kamping S, Flöel A et al. Levodopa: faster and better word learning in normal humans. Ann Neurol 2004;56:20-6. (Pubitemid 38857356)
15. Kobayashi H, Nakagawa T, Sekizawa K, Arai H, Sasaki H. Levodopa and swallowing reflex. Lancet 1996;348:1320-1.
16. Mohr C, Landis T, Bracha HS, Fathi M, Brugger P. Human locomotion: levodopa keeps you straight. Neurosci Lett 2003;339:115-8. (Pubitemid 36254790)
17. Scheidtmann K, Fries W, Muller F, Koenig E. Effect of levodopa in combination with physiotherapy on functional motor recovery after stroke: a prospective, randomised, double-blind study. Lancet 2001;358:787-90. (Pubitemid 32868727)
18. Sonde L, Lokk J. Effects of amphetamine and/or L-dopa and physiotherapy after stroke - a blinded randomized study. Acta Neurol Scand 2007;115:55-9. (Pubitemid 44915499)
19. Seniow J, Litwin M, Litwin T, Lesniak M, Czlonkowska A. New approach to the rehabilitation of post-stroke focal cognitive syndrome: effect of levodopa combined with speech and language therapy on functional recovery from aphasia. J Neurol Sci 2009;283:214-8.
20. Floel A, Hummel F, Breitenstein C, Knecht S, Cohen LG. Dopaminergic effects on encoding of a motor memory in chronic stroke. Neurology 2005;65:472-4. (Pubitemid 41099818)
21. Engelter ST, Frank M, Lyrer PA, Conzelmann M. Safety of pharmacological augmentation of stroke rehabilitation. Eur Neurol 2010;64:325-30.
22. Cramer SC, Dobkin BH, Noser EA, Rodriguez RW, Enney LA. Randomized, placebo-controlled, double-blind study of ropinirole in chronic stroke. Stroke 2009;40:3034-8.
23. Bakheit AM. Drug treatment of poststroke aphasia. Expert Rev Neurother 2004;4:211-7. (Pubitemid 38315941)
24. Pariente J, Loubinoux I, Carel C, Albucher JF, Leger A, Manelfe C et al. Fluoxetine modulates motor performance and cerebral activation of patients recovering from stroke. Ann Neurol 2001;50:718-29. (Pubitemid 33116131)
25. Chollet F, Tardy J, Albucher JF, Thalamas C, Berard E, Lamy C et al. Fluoxetine for motor recovery after acute ischaemic stroke FLAME): a randomised placebo-controlled trial. Lancet Neurol 2011;10:123-30.
26. Jorge RE, Acion L, Moser D, Adams HP Jr, Robinson RG. Escitalopram and enhancement of cognitive recovery following stroke. Arch Gen Psychiatry 2010;67:187-96.
27. Robinson RG, Jorge RE, Moser DJ, Acion L, Solodkin A, Small SL et al. Escitalopram and problem-solving therapy for prevention of poststroke depression: a randomized controlled trial. JAMA 2008;299:2391-400. (Pubitemid 351749237)
28. Acler M, Robol E, Fiaschi A, Manganotti P. A double blind placebo RCT to investigate the effects of serotonergic modulation on brain excitability and motor recovery in stroke patients. J Neurol 2009;256:1152-8.
29. Zittel S, Weiller C, Liepert J. Citalopram improves dexterity in chronic stroke patients. Neurorehabil Neural Repair 2008;22:311-4. (Pubitemid 351561669)
30. Zittel S, Weiller C, Liepert J. Reboxetine improves motor function in chronic stroke. A pilot study. J Neurol 2007;254:197-201. (Pubitemid 46356052)
31. Berthier ML, Green C, Higueras C, Fernandez I, Hinojosa J, Martin MC. A randomized, placebo-controlled study of donepezil in poststroke aphasia. Neurology 2006;67:1687-9. (Pubitemid 44747948)
32. Berthier ML, Pujol J, Gironell A, Kulisevsky J, Deus J, Hinojosa J et al. Beneficial effect of donepezil on sensorimotor function after stroke. AmJ Phys Med Rehabil 2003;82:725-9. (Pubitemid 37022523)
33. Whyte EM, Lenze EJ, Butters M, Skidmore E, Koenig K, Dew MA et al. An open-label pilot study of acetylcholinesterase inhibitors to promote functional recovery in elderly cognitively impaired stroke patients. Cerehrovasc Dis 2008;26:317-21.
34. Dichgans M, Markus HS, Salloway S, Verkkoniemi A, Moline M, Wang Q et al. Donepezil in patients with subcortical vascular cognitive impairment: a randomised double-blind trial in CADASIL. Lancet Neurol 2008;7:310-8.
35. Ricci S, Celani MG, Cantisani AT, Righetti E. Piracetam for acute ischaemic stroke. Cochrane Database Syst Rev 2006;CD000419.
36. Greener J, Enderby P, Whurr R. Pharmacological treatment for aphasia following stroke. Cochrane Database Syst Rev 2001;CD000424.
37. Bakiri Y, Hamilton NB, Karadottir R, Attwell D. Testing NMDA receptor block as a therapeutic strategy for reducing ischaemic damage to CNS white matter. Glia 2008;56:233-240. (Pubitemid 350292315)
38. Kim YW, Shin JC, An YS. Changes in cerebral glucose metabolism in patients with posttraumatic cognitive impairment after memantine therapy: a preliminary study. Ann Nucl Med 2010;24:363-9.
39. Berthier ML, Green C, Lara JP, Higueras C, Barbancho MA, Dávila G et al. Memantine and constraint-induced aphasia therapy in chronic poststroke aphasia. Ann Neurol 2009;65:577-85.
40. Montagne A, Hébert M, Jullienne A, Lesept F, Le Béhot A, Louessard M et al. Memantine improves safety of thrombolysis for stroke. Stroke 2012;43:2774-81.
41. Martinsson L, Hardemark H, Eksborg S. Amphetamines for improving recovery after stroke. Cochrane Database Syst Rev 2007;CD002090.
42. Schuster C, Maunz G, Lutz K, Kischka U, Sturzenegger R, Ettlin T. Dexamphetamine improves upper extremity outcome during rehabilitation after stroke: a pilot randomized controlled trial. Neurorehabil Neural Repair 2011;25:749-755.
43. Peeters M, Page G, Maloteaux JM, Hermans E. Hypersensitivity of dopamine transmission in the rat striatum after treatment with the NMDA receptor antagonist amantadine. Brain Res 2002;949:32-41. (Pubitemid 35246174)
44. Sawyer E, Mauro LS, Ohlinger MJ. Amantadine enhancement of arousal and cognition after traumatic brain injury. Ann Pharmacother 2008;42:247-52. (Pubitemid 351238573)
45. Giacino JT, Whyte J, Bagiella E, Kalmar K, Childs N, Khademi A et al. Placebo-controlled trial of amantadine for severe traumatic brain injury. N Engl J Med 2012;366:819-26.
46. Grade C, Redford B, Chrostowski J, Toussaint L, Blackwell B. Methylphenidate in early poststroke recovery: a double-blind, placebo-controlled study. Arch Phys Med Rehabil 1998;79:1047-50. (Pubitemid 28419310)
47. Lokk J, Salman RR, Delbari A. Effect of methylphenidate and/or levodopa coupled with physiotherapy on functional and motor recovery after stroke-a randomized, double-blind, placebocontrolled trial. Acta Neurol Scand 2011;123:266-73.
48. Delbari A, Salman-Roghani R, Lokk J. Effect of methylphenidate and/or levodopa combined with physiotherapy on mood and cognition after stroke: A randomized, double-blind, placebo-controlled trial. Eur Neurol 2011;66:7-13.
49. Brioschi A, Gramigna S, Werth E, Staub F, Ruffieux C, Bassetti C et al. Effect of modafinil on subjective fatigue in multiple sclerosis and stroke patients. Eur Neurol 2009;62:243-9.
50. Engelter ST, Urscheler N, Baronti F, Vuadens P, Koch J, Frank M et al. Frequency and determinants of using pharmacological enhancement in the clinical practice of in-hospital stroke rehabilitation. Eur Neurol 2012;68:28-33.
51. Bhakta B. Dopamine Augmented Rehabilitation in Stroke DARS) A multicentre randomised double blind placebo-controlled trial, [cited 2013 January 91- Available at: http://www. controlled-trials.com/ISRCTN99643613ASRCTN99643613; last access: November 4th 2012).
52. Effect of F2695 on Functional Recovery After Ischemic Stroke LIFE); ClinicalTrials.gov Identifier, [cited 2013 January 9]. Available at: http://clinicaltrials.gov/ct2/show/NCT01639014; last access November 4th 2012)
53. ESTREL - Enhancement of Stroke Rehabilitation with Levodopa. A randomized, placebo-controlled multicenter trial. Swiss Stroke Society: [cited 2013 January 9]. Available at: http://www. neurovasc.ch/index.php/ neurorehabilitation-und-spaetkomplikationen.html; last access November 4th 2012.